ArticleEye (London, England)2026
Rethinking phase III trials in retinal biosimilars: Do we still need them?
Ashish Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEye (London, England)2026
Ashish Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.